Financials in USD. Standardized financial statements.
A compact view of how Primemd Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
|---|---|---|---|---|---|---|---|
| Revenue? | $10.50M | $67,802 | $49,147 | $52,640 | $39,128 | $57,927 | $58,241 |
| Revenue Growth? | +15388.8% | +38.0% | -6.6% | +34.5% | -32.5% | -0.5% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $10.50M | $67,802 | $49,147 | $52,640 | $39,128 | $57,927 | $58,241 |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $6.26M | $171,509 | $261,615 | $210,598 | $228,592 | $216,010 | $196,583 |
| Operating Income? | $4.16M | -$107,380 | -$216,130 | -$165,210 | -$199,090 | -$174,460 | -$145,320 |
| EBITDA? | $3.43M | -$103,707 | -$212,468 | -$157,958 | -$189,464 | -$158,082 | -$138,342 |
| Income Before Tax | $3.14M | -$101,123 | $194,717 | -$155,518 | -$159,384 | -$147,755 | -$842,812 |
| Income Tax Expense | $0 | $4 | $5 | -$2 | $2 | -$4 | $5 |
| Net Income? | $3.14M | -$101,123 | $194,717 | -$155,518 | -$159,384 | -$147,755 | -$842,812 |
| EPS? | $0.17 | $-0.03 | $0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.27 |
| Diluted EPS? | $0.17 | $-0.03 | $0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.27 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality